Oxford, United Kingdom

Min Lu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Lu. Retrieved from https://idiyas.com/inventor/min-lu-8tylzt1t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Lu: Innovator in Cancer Research

Introduction

Min Lu is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of cancer research, particularly in understanding the metastatic potential of cancer cells. His innovative work has led to the development of diagnostic methods that can evaluate cancer progression.

Latest Patents

Min Lu holds a patent titled "iASPP phosphorylation and metastatic potential." This patent describes methods for evaluating the metastatic potential of cancer based on the phosphorylation state and intracellular localization of iASPP. Additionally, it provides therapeutic regimens designed based on the results of these diagnostic methods.

Career Highlights

Throughout his career, Min Lu has worked with notable organizations such as the Ludwig Institute for Cancer Research Limited and Oxford University Innovation Limited. His work in these institutions has furthered the understanding of cancer biology and therapeutic approaches.

Collaborations

Min Lu has collaborated with esteemed colleagues, including Xin Lu and Richard Guy Compton. These partnerships have enhanced the impact of his research and contributed to advancements in cancer treatment.

Conclusion

Min Lu's innovative contributions to cancer research, particularly through his patent on iASPP phosphorylation, highlight his role as a key figure in the scientific community. His work continues to influence the development of diagnostic and therapeutic strategies in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…